株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

インターベンショナルX線 (IXR) における造影剤の世界市場:産業動向・予測

Global Contrast and Imaging Agents in Interventional X-ray Market Industry Trends Forecast to 2026

発行 Data Bridge Market Research Private Limited 商品コード 785816
出版日 ページ情報 英文 194 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=109.53円で換算しております。
Back to Top
インターベンショナルX線 (IXR) における造影剤の世界市場:産業動向・予測 Global Contrast and Imaging Agents in Interventional X-ray Market Industry Trends Forecast to 2026
出版日: 2019年01月18日 ページ情報: 英文 194 Pages
概要

当レポートでは、インターベンショナルX線 (IXR) における造影剤の世界市場を調査し、市場の概要、造影剤の種類、用途、エンドユーザー、および地域別の市場動向、市場規模の推移と予測、市場の将来展望、競合情勢、主要企業のプロファイルなどを包括的にまとめています。

第1章 イントロダクション

第2章 市場区分

第3章 市場概要

  • 促進要因
  • 抑制要因
  • 機会
  • 課題

第4章 エグゼクティブサマリー

第5章 重要考察

第6章 主な重要考察

第7章 インターベンショナルX線 (IXR) における造影剤の世界市場:造影剤の種類別

  • 概要
  • ヨード造影剤
  • バリウムベース造影剤
  • マイクロバルブ造影剤
  • 金ナノ粒子造影剤
  • その他

第8章 インターベンショナルX線 (IXR) における造影剤の世界市場:用途別

  • 概要
  • 心臓病学
  • 消化器科
  • 神経学
  • 泌尿器科
  • 一般外科

第9章 インターベンショナルX線 (IXR) における造影剤の世界市場:エンドユーザー別

  • 概要
  • 画像センター
  • 病院
  • クリニック
  • 診断センター
  • 外来外科センター
  • 開業医

第10章 インターベンショナルX線 (IXR) における造影剤の世界市場:地域別

  • 概要
  • 北米
  • 欧州
  • アジア太平洋
  • 南米
  • 中東・アフリカ

第11章 企業情勢

  • 世界
  • 北米
  • 欧州
  • アジア太平洋

第12章 企業プロファイル

  • BRACCO
  • GENERAL ELECTRIC COMPANY
  • GUERBET
  • FUJIFILM VISUALSONICS INC.
  • IMAX
  • J.B. CHEMICALS & PHARMACEUTICALS LTD.
  • JODAS EXPOIM
  • LANTHEUS MEDICAL IMAGING, INC.
  • NANO THERAPEUTICS PVT. LTD.
  • NOVALEK PHARMACEUTICALS PVT. LTD.
  • TAEJOON PHARM
  • UNIJULES LIFE SCIENCES LTD.

第13章 アンケート

第14章 関連レポート

図表

LIST OF TABLES

  • TABLE 1 TOTAL AGEING POPULATION IN TURKEY AND IRAN 39
  • TABLE 2 NUMBER OF DIAGNOSTIC IMAGING EQUIPMENT IN CANADA (2007 & 2017) 40
  • TABLE 3 RESEARCH AND DEVELOPMENT EXPENDITURE FOR COMPANIES (USD MILLION) (2016 & 2017) 41
  • TABLE 4 AMOUNT OF CONTRAST MEDIA TO BE TAKEN AS PER PATIENT'S WEIGHT 46
  • TABLE 5 GLOBAL CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2017-2026 (USD MILLION) 56
  • TABLE 6 GLOBAL CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, IODINATED CONTRAST MEDIA, BY REGION, 2017-2026 (USD MILLION) 56
  • TABLE 7 GLOBAL CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BARIUM-BASED CONTRAST MEDIA, BY REGION, 2017-2026 (USD MILLION) 57
  • TABLE 8 GLOBAL CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, MICROBUBBLE CONTRAST MEDIA, BY REGION, 2017-2026 (USD MILLION) 57
  • TABLE 9 GLOBAL CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, GOLD NANOPARTICLE CONTRAST AGENTS, BY REGION, 2017-2026 (USD MILLION) 58
  • TABLE 10 GLOBAL CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, OTHERS, BY REGION, 2017-2026 (USD MILLION) 58
  • TABLE 11 GLOBAL CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 61
  • TABLE 12 GLOBAL CARDIOLOGY CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 62
  • TABLE 13 GLOBAL CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, CARDIOLOGY, BY REGION, 2017-2026 (USD MILLION) 62
  • TABLE 14 GLOBAL CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, GASTROENTEROLOGY, BY REGION, 2017-2026 (USD MILLION) 63
  • TABLE 15 GLOBAL CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, NEUROLOGY, BY REGION, 2017-2026 (USD MILLION) 64
  • TABLE 16 GLOBAL CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, ONCOLOGY, BY REGION, 2017-2026 (USD MILLION) 64
  • TABLE 17 GLOBAL CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, UROLOGY, BY REGION, 2017-2026 (USD MILLION) 65
  • TABLE 18 GLOBAL CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, GENERAL SURGERY, BY REGION, 2017-2026 (USD MILLION) 65
  • TABLE 19 GLOBAL CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2017-2026 (USD MILLION) 68
  • TABLE 20 GLOBAL CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, IMAGING CENTERS, BY REGION, 2017-2026 (USD MILLION) 68
  • TABLE 21 GLOBAL CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, HOSPITAL, BY REGION, 2017-2026 (USD MILLION) 69
  • TABLE 22 GLOBAL CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, CLINICS, BY REGION, 2017-2026 (USD MILLION) 69
  • TABLE 23 GLOBAL CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, DIAGNOSTIC CENTER, BY REGION, 2017-2026 (USD MILLION) 70
  • TABLE 24 GLOBAL CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, AMBULATORY SURGICAL CENTERS, BY REGION, 2017-2026 (USD MILLION) 70
  • TABLE 25 GLOBAL CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, PRIVATE PRACTICES, BY REGION, 2017-2026 (USD MILLION) 71
  • TABLE 26 GLOBAL CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY REGION, 2017-2026 (USD MILLION) 77
  • TABLE 27 NORTH AMERICA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY COUNTRY, 2017-2026 (USD MILLION) 81
  • TABLE 28 NORTH AMERICA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2017-2026 (USD MILLION) 81
  • TABLE 29 NORTH AMERICA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 82
  • TABLE 30 NORTH AMERICA CARDIOLOGY IN CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 82
  • TABLE 31 NORTH AMERICA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2017-2026 (USD MILLION) 83
  • TABLE 32 U.S. CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2017-2026 (USD MILLION) 84
  • TABLE 33 U.S. CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 84
  • TABLE 34 U.S. CARDIOLOGY IN CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 85
  • TABLE 35 U.S. CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2017-2026 (USD MILLION) 85
  • TABLE 36 CANADA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2017-2026 (USD MILLION) 86
  • TABLE 37 CANADA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 86
  • TABLE 38 CANADA CARDIOLOGY IN CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 87
  • TABLE 39 CANADA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2017-2026 (USD MILLION) 87
  • TABLE 40 MEXICO CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2017-2026 (USD MILLION) 88
  • TABLE 41 MEXICO CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 88
  • TABLE 42 MEXICO CARDIOLOGY IN CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 89
  • TABLE 43 MEXICO CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2017-2026 (USD MILLION) 89
  • TABLE 44 EUROPE CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY COUNTRY, 2017-2026 (USD MILLION) 93
  • TABLE 45 EUROPE CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2017-2026 (USD MILLION) 93
  • TABLE 46 EUROPE CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 94
  • TABLE 47 EUROPE CARDIOLOGY IN CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 94
  • TABLE 48 EUROPE CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2017-2026 (USD MILLION) 95
  • TABLE 49 GERMANY CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2017-2026 (USD MILLION) 96
  • TABLE 50 GERMANY CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 96
  • TABLE 51 GERMANY CARDIOLOGY IN CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 97
  • TABLE 52 GERMANY CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2017-2026 (USD MILLION) 97
  • TABLE 53 U.K. CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2017-2026 (USD MILLION) 98
  • TABLE 54 U.K. CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 98
  • TABLE 55 U.K. CARDIOLOGY IN CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 99
  • TABLE 56 U.K. CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2017-2026 (USD MILLION) 99
  • TABLE 57 FRANCE CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2017-2026 (USD MILLION) 100
  • TABLE 58 FRANCE CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 100
  • TABLE 59 FRANCE CARDIOLOGY IN CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 101
  • TABLE 60 FRANCE CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2017-2026 (USD MILLION) 101
  • TABLE 61 ITALY CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2017-2026 (USD MILLION) 102
  • TABLE 62 ITALY CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 102
  • TABLE 63 ITALY CARDIOLOGY IN CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 103
  • TABLE 64 ITALY CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2017-2026 (USD MILLION) 103
  • TABLE 65 SPAIN CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2017-2026 (USD MILLION) 104
  • TABLE 66 SPAIN CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 104
  • TABLE 67 ITALY CARDIOLOGY IN CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 105
  • TABLE 68 SPAIN CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2017-2026 (USD MILLION) 105
  • TABLE 69 SWITZERLAND CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2017-2026 (USD MILLION) 106
  • TABLE 70 SWITZERLAND CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 106
  • TABLE 71 SWITZERLAND CARDIOLOGY IN CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 107
  • TABLE 72 SWITZERLAND CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2017-2026 (USD MILLION) 107
  • TABLE 73 NETHERLANDS CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2017-2026 (USD MILLION) 108
  • TABLE 74 NETHERLANDS CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 108
  • TABLE 75 NETHERLANDS CARDIOLOGY IN CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 109
  • TABLE 76 NETHERLANDS CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2017-2026 (USD MILLION) 109
  • TABLE 77 RUSSIA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2017-2026 (USD MILLION) 110
  • TABLE 78 RUSSIA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 110
  • TABLE 79 RUSSIA CARDIOLOGY IN CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 111
  • TABLE 80 RUSSIA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2017-2026 (USD MILLION) 111
  • TABLE 81 BELGIUM CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2017-2026 (USD MILLION) 112
  • TABLE 82 BELGIUM CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 112
  • TABLE 83 BELGIUM CARDIOLOGY IN CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 113
  • TABLE 84 BELGIUM CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2017-2026 (USD MILLION) 113
  • TABLE 85 TURKEY CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2017-2026 (USD MILLION) 114
  • TABLE 86 TURKEY CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 114
  • TABLE 87 TURKEY CARDIOLOGY IN CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 115
  • TABLE 88 TURKEY CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2017-2026 (USD MILLION) 115
  • TABLE 89 BELGIUM CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2017-2026 (USD MILLION) 116
  • TABLE 90 ASIA PACIFIC CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY COUNTRY, 2017-2026 (USD MILLION) 120
  • TABLE 91 ASIA PACIFIC CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2017-2026 (USD MILLION) 120
  • TABLE 92 ASIA PACIFIC CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 121
  • TABLE 93 ASIA PACIFIC CARDIOLOGY IN CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 121
  • TABLE 94 ASIA PACIFIC CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2017-2026 (USD MILLION) 122
  • TABLE 95 CHINA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2017-2026 (USD MILLION) 123
  • TABLE 96 CHINA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 123
  • TABLE 97 CHINA CARDIOLOGY IN CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 124
  • TABLE 98 CHINA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2017-2026 (USD MILLION) 124
  • TABLE 99 JAPAN CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2017-2026 (USD MILLION) 125
  • TABLE 100 JAPAN CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 125
  • TABLE 101 JAPAN CARDIOLOGY IN CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 126
  • TABLE 102 JAPAN CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2017-2026 (USD MILLION) 126
  • TABLE 103 INDIA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2017-2026 (USD MILLION) 127
  • TABLE 104 INDIA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 127
  • TABLE 105 INDIA CARDIOLOGY IN CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 128
  • TABLE 106 INDIA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2017-2026 (USD MILLION) 128
  • TABLE 107 AUSTRALIA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2017-2026 (USD MILLION) 129
  • TABLE 108 AUSTRALIA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 129
  • TABLE 109 AUSTRALIA CARDIOLOGY IN CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 130
  • TABLE 110 AUSTRALIA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2017-2026 (USD MILLION) 130
  • TABLE 111 SOUTH KOREA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2017-2026 (USD MILLION) 131
  • TABLE 112 SOUTH KOREA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 131
  • TABLE 113 SOUTH KOREA CARDIOLOGY IN CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 132
  • TABLE 114 SOUTH KOREA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2017-2026 (USD MILLION) 132
  • TABLE 115 SINGAPORE CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2017-2026 (USD MILLION) 133
  • TABLE 116 SINGAPORE CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 133
  • TABLE 117 SINGAPORE CARDIOLOGY IN CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 134
  • TABLE 118 SINGAPORE CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2017-2026 (USD MILLION) 134
  • TABLE 119 MALAYSIA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2017-2026 (USD MILLION) 135
  • TABLE 120 MALAYSIA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 135
  • TABLE 121 MALAYSIA CARDIOLOGY IN CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 136
  • TABLE 122 MALAYSIA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2017-2026 (USD MILLION) 136
  • TABLE 123 INDONESIA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2017-2026 (USD MILLION) 137
  • TABLE 124 INDONESIA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 137
  • TABLE 125 INDONESIA CARDIOLOGY IN CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 138
  • TABLE 126 INDONESIA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2017-2026 (USD MILLION) 138
  • TABLE 127 THAILAND CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2017-2026 (USD MILLION) 139
  • TABLE 128 THAILAND CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 139
  • TABLE 129 THAILAND CARDIOLOGY CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 140
  • TABLE 130 THAILAND CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2017-2026 (USD MILLION) 140
  • TABLE 131 PHILIPPINES CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2017-2026 (USD MILLION) 141
  • TABLE 132 PHILIPPINES CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 141
  • TABLE 133 PHILIPPINES CARDIOLOGY IN CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 142
  • TABLE 134 PHILIPPINES CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2017-2026 (USD MILLION) 142
  • TABLE 135 REST OF ASIA-PACIFIC CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2017-2026 (USD MILLION) 143
  • TABLE 136 SOUTH AMERICA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY COUNTRY, 2017-2026 (USD MILLION) 147
  • TABLE 137 SOUTH AMERICA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2017-2026 (USD MILLION) 147
  • TABLE 138 SOUTH AMERICA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 148
  • TABLE 139 SOUTH AMERICA CARDIOLOGY IN CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 148
  • TABLE 140 SOUTH AMERICA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2017-2026 (USD MILLION) 149
  • TABLE 141 BRAZIL CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2017-2026 (USD MILLION) 150
  • TABLE 142 BRAZIL CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 150
  • TABLE 143 BRAZIL CARDIOLOGY IN CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 151
  • TABLE 144 BRAZIL CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2017-2026 (USD MILLION) 151
  • TABLE 145 REST OF SOUTH AMERICA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2017-2026 (USD MILLION) 152
  • TABLE 146 MIDDLE EAST & AFRICA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY COUNTRY, 2017-2026 (USD MILLION) 156
  • TABLE 147 MIDDLE EAST & AFRICA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2017-2026 (USD MILLION) 156
  • TABLE 148 MIDDLE EAST & AFRICA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 157
  • TABLE 149 MIDDLE EAST & AFRICA CARDIOLOGY IN CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 157
  • TABLE 150 MIDDLE EAST & AFRICA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2017-2026 (USD MILLION) 158
  • TABLE 151 SOUTH AFRICA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2017-2026 (USD MILLION) 159
  • TABLE 152 SOUTH AFRICA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 159
  • TABLE 153 SOUTH AFRICA CARDIOLOGY IN CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION, 2017-2026 (USD MILLION) 160
  • TABLE 154 SOUTH AFRICA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY END USER, 2017-2026 (USD MILLION) 160
  • TABLE 155 REST OF MIDDLE EAST & AFRICA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE, 2017-2026 (USD MILLION) 161

LIST OF FIGURES

  • FIGURE 1 GLOBAL CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET: SEGMENTATION 24
  • FIGURE 2 GLOBAL CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET: DATA TRIANGULATION 27
  • FIGURE 3 GLOBAL CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET: DROC ANALYSIS 28
  • FIGURE 4 GLOBAL CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET: BOTTOM UP APPROACH 29
  • FIGURE 5 GLOBAL CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET: TOP DOWN APPROACH 29
  • FIGURE 6 GLOBAL CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET: INTERVIEW DEMOGRAPHICS 30
  • FIGURE 7 GLOBAL CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET: THE MARKET CHALLENGE MATRIX 31
  • FIGURE 8 GLOBAL CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET: MARKET APPLICATION COVERAGE GRID 32
  • FIGURE 9 GLOBAL CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET: DBMR VENDOR SHARE ANALYSIS 33
  • FIGURE 10 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF GLOBAL CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET 36
  • FIGURE 11 AGEING POPULATION OF CANADA (% OF TOTAL) 38
  • FIGURE 12 TOTAL POPULATION OF AGES 65 AND ABOVE (% OF TOTAL) IN 2015 & 2016 39
  • FIGURE 13 TOTAL NUMBER OF PHYSICIANS IN CANADA, (2015 & 2018) 40
  • FIGURE 14 TOTAL HEALTH SPENDING PER CANADIAN (USD) (2017 & 2018) 43
  • FIGURE 15 TOTAL CANADA HEALTH EXPENDITURE, BY SOURCE OF FINANCE, 2016 (USD BILLIONS) 43
  • FIGURE 16 HEALTH EXPENDITURE PER CAPITA IN PPP INTERNATIONAL USD 44
  • FIGURE 17 TOTAL NUMBER OF HOSPITALS IN CANADA (2015& 2016) 45
  • FIGURE 18 GLOBAL CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET: SEGMENTATION 48
  • FIGURE 19 NORTH AMERICA IS ANTICIPATED TO DOMINATE CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET AND ASIA PACIFIC IS ESTIMATED TO BE INCREASING WITH THE STRONG CAGR IN THE FORECAST PERIOD FROM 2019 TO 2026 49
  • FIGURE 20 RISING NUMBER OF CHRONIC DISEASES, RISING AGING POPULATION, GROWING NUMBER OF DIAGNOSIC CENTRES AND INCREASE IN THE RESEARCH AND DEVELOPMENTAL ACTIVITIES OF CONTRAST AGENTS ARE DRIVING THE MARKET FOR GLOBAL CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY IN THE FORECAST PERIOD OF 2019 TO 2026 50
  • FIGURE 21 IODINATED CONTRAST MEDIA SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET IN 2019 & 2026 51
  • FIGURE 22 ASIA -PACIFIC IS THE MAXIMUM GROWING AND MOST PROFITABLE REVENUE POCKETS FOR CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET IN THE FORECAST PERIOD FROM 2019 TO 2026 52
  • FIGURE 23 GLOBAL CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET: BY AGENT TYPE, 2018 55
  • FIGURE 24 GLOBAL CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET: BY APPLICATION, 2018 60
  • FIGURE 25 GLOBAL CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET: BY END USER, 2018 67
  • FIGURE 26 GLOBAL CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET SNAPSHOT (2018) 74
  • FIGURE 27 GLOBAL CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET: BY GEOGRAPHY (2018) 75
  • FIGURE 28 GLOBAL CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET: BY GEOGRAPHY (2019 & 2026) 75
  • FIGURE 29 GLOBAL CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET: BY GEOGRAPHY (2018 & 2026) 76
  • FIGURE 30 GLOBAL CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET: BY AGENT TYPE (2019 - 2026) 76
  • FIGURE 31 NORTH AMERICA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET SNAPSHOT (2018) 78
  • FIGURE 32 NORTH AMERICA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET: BY COUNTRY (2018) 79
  • FIGURE 33 NORTH AMERICA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET: BY COUNTRY (2019 & 2026) 79
  • FIGURE 34 NORTH AMERICA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET: BY COUNTRY (2018 & 2026) 80
  • FIGURE 35 NORTH AMERICA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET: BY AGENT TYPE (2019 - 2026) 80
  • FIGURE 36 EUROPE CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET SNAPSHOT (2018) 90
  • FIGURE 37 EUROPE CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET: BY COUNTRY (2018) 91
  • FIGURE 38 EUROPE CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET: BY COUNTRY (2019 & 2026) 91
  • FIGURE 39 EUROPE CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET: BY COUNTRY (2018 & 2026) 92
  • FIGURE 40 EUROPE CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET: BY AGENT TYPE (2019 - 2026) 92
  • FIGURE 41 ASIA PACIFIC CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET SNAPSHOT (2018) 117
  • FIGURE 42 ASIA PACIFIC CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET: BY COUNTRY (2018) 118
  • FIGURE 43 ASIA PACIFIC CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET: BY COUNTRY (2019 & 2026) 118
  • FIGURE 44 ASIA PACIFIC CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET: BY COUNTRY (2018 & 2026) 119
  • FIGURE 45 ASIA PACIFIC CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET: BY AGENT TYPE (2019 - 2026) 119
  • FIGURE 46 SOUTH AMERICA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET SNAPSHOT (2018) 144
  • FIGURE 47 SOUTH AMERICA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET: BY COUNTRY (2018) 145
  • FIGURE 48 SOUTH AMERICA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET: BY COUNTRY (2019 & 2026) 145
  • FIGURE 49 SOUTH AMERICA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET: BY COUNTRY (2018 & 2026) 146
  • FIGURE 50 SOUTH AMERICA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET: BY AGENT TYPE (2019 - 2026) 146
  • FIGURE 51 MIDDLE EAST & AFRICA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET SNAPSHOT (2018) 153
  • FIGURE 52 MIDDLE EAST & AFRICA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET: BY COUNTRY (2018) 154
  • FIGURE 53 MIDDLE EAST & AFRICA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET: BY COUNTRY (2019 & 2026) 154
  • FIGURE 54 MIDDLE EAST & AFRICA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET: BY COUNTRY (2018 & 2026) 155
  • FIGURE 55 MIDDLE EAST & AFRICA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET: BY AGENT TYPE (2019 - 2026) 155
  • FIGURE 56 GLOBAL CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET: COMPANY SHARE 2018 (%) 162
  • FIGURE 57 NORTH AMERICA CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET: COMPANY SHARE 2018 (%) 163
  • FIGURE 58 EUROPE CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET: COMPANY SHARE 2018 (%) 164
  • FIGURE 59 ASIA PACIFIC CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET: COMPANY SHARE 2018 (%) 165
目次

Global contrast and imaging agents in interventional X-ray market is projected to register a healthy CAGR of 5.6% in the forecast period 2019 to 2026. The new market report contains data for historic years 2017, the base year of calculation is 2018 and the forecast period is 2019 to 2026.

Market Segmentation:

By Agent Type (Iodinated Contrast Media, Barium-Based Contrast Media, Microbubble Contrast Media, Gold Nanoparticle Contrast Agents, Others), Application (Cardiology, Gastroenterology, Neurology, Oncology, Urology, General Surgery), End User (Imaging Centers, Hospital, Clinics, Diagnostic Center, Ambulatory Surgical Centers, Private Practices), Geography (North America, Europe, Asia-Pacific, South America and Middle East and Africa)

Major growing sectors under the market segmentation are as follows:

  • In agent type, iodinated contrast media is dominating as well as the fastest growing segment in the market.
  • In application, cardiology is dominating as well as the fastest growing segment in the market.
  • In end user, imaging centers is dominating as well as the fastest growing segment in the market.

Market Players:

The key market players for global contrast and imaging agents in interventional X-ray market are listed below:

  • General Electric Company
  • BRACCO
  • Guerbet
  • Lantheus Medical Imaging, Inc.
  • FUJIFILM VisualSonics Inc.
  • Jodas Expoim
  • TAEJOON PHARM
  • Unijules Life Sciences Ltd.
  • J.B.Chemicals & Pharmaceuticals Ltd.
  • iMAX
  • Novalek Pharmaceuticals Pvt. Ltd.
  • Nano Therapeutics Pvt Ltd
  • Others

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 OVERVIEW OF GLOBAL CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET
  • 1.4 CURRENCY AND PRICING
  • 1.5 LIMITATION
  • 1.6 MARKETS COVERED

2 MARKET SEGMENTATION

  • 2.1 MARKETS COVERED
  • 2.2 GEOGRAPHIC SCOPE
  • 2.3 YEARS CONSIDERED FOR THE STUDY
  • 2.4 CURRENCY AND PRICING
  • 2.5 RESEARCH METHODOLOGY
  • 2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
  • 2.7 DBMR MARKET CHALLENGE MATRIX
  • 2.8 MARKET APPLICATION COVERAGE GRID
  • 2.9 DBMR VENDOR SHARE ANALYSIS
  • 2.10 SECONDARY SOURCES
  • 2.11 ASSUMPTIONS

3 MARKET OVERVIEW

  • 3.1 DRIVERS
    • 3.1.1 RISING NUMBER OF CHRONIC DISEASES
    • 3.1.2 RISING AGING POPULATION
    • 3.1.3 GROWING NUMBER OF DIAGNOSTIC CENTERS
    • 3.1.4 INCREASE IN THE RESEARCH AND DEVELOPMENTAL ACTIVITIES OF CONTRAST AGENTS
  • 3.2 RESTRAINT
    • 3.2.1 SIDE EFFECTS ASSOCIATED WITH CONTRAST AGENTS
  • 3.3 OPPORTUNITIES
    • 3.3.1 RISING HEALTHCARE EXPENDITURE
    • 3.3.2 INCREASE IN NUMBER OF PUBLIC AND PRIVATE HOSPITALS
  • 3.4 CHALLENGE
    • 3.4.1 LACK OF AWARENESS REGARDING THE PROPER DOSAGE OF CONTRAST AGENT

4 EXECUTIVE SUMMARY

5 PREMIUM INSIGHTS

6 KEY PRIMARY INSIGHTS

7 GLOBAL CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY AGENT TYPE

  • 7.1 OVERVIEW
  • 7.2 IODINATED CONTRAST MEDIA
  • 7.3 BARIUM-BASED CONTRAST MEDIA
  • 7.4 MICROBUBBLE CONTRAST MEDIA
  • 7.5 GOLD NANOPARTICLE CONTRAST AGENTS
  • 7.6 OTHERS

8 GLOBAL CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY APPLICATION

  • 8.1 OVERVIEW
  • 8.2 CARDIOLOGY
    • 8.2.1 PERCUTANEOUS CORONARY INTERVENTION
    • 8.2.2 STRUCTURAL HEART DISEASE
    • 8.2.3 CONGENITAL HEART DISEASE
    • 8.2.4 ELECTROPHYSIOLOGY
  • 8.3 GASTROENTEROLOGY
  • 8.4 NEUROLOGY
  • 8.5 ONCOLOGY
  • 8.6 UROLOGY
  • 8.7 GENERAL SURGERY

9 GLOBAL CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY END USER

  • 9.1 OVERVIEW
  • 9.2 IMAGING CENTERS
  • 9.3 HOSPITAL
  • 9.4 CLINICS
  • 9.5 DIAGNOSTIC CENTER
  • 9.6 AMBULATORY SURGICAL CENTERS
  • 9.7 PRIVATE PRACTICES

10 GLOBAL CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, BY GEOGRAPHY

  • 10.1 OVERVIEW
  • 10.2 NORTH AMERICA
    • 10.2.1 U.S.
    • 10.2.2 CANADA
    • 10.2.3 MEXICO
  • 10.3 EUROPE
    • 10.3.1 GERMANY
    • 10.3.2 U.K.
    • 10.3.3 FRANCE
    • 10.3.4 ITALY
    • 10.3.5 SPAIN
    • 10.3.6 SWITZERLAND
    • 10.3.7 NETHERLANDS
    • 10.3.8 RUSSIA
    • 10.3.9 BELGIUM
    • 10.3.10 TURKEY
    • 10.3.11 REST OF EUROPE
  • 10.4 ASIA PACIFIC
    • 10.4.1 CHINA
    • 10.4.2 JAPAN
    • 10.4.3 INDIA
    • 10.4.4 AUSTRALIA
    • 10.4.5 SOUTH KOREA
    • 10.4.6 SINGAPORE
    • 10.4.7 MALAYSIA
    • 10.4.8 INDONESIA
    • 10.4.9 THAILAND
    • 10.4.10 PHILIPPINES
    • 10.4.11 REST OF ASIA PACIFIC
  • 10.5 SOUTH AMERICA
    • 10.5.1 BRAZIL
    • 10.5.2 REST OF SOUTH AMERICA
  • 10.6 MIDDLE EAST & AFRICA
    • 10.6.1 SOUTH AFRICA
    • 10.6.2 REST OF MIDDLE EAST & AFRICA

11 GLOBAL CONTRAST AND IMAGING AGENTS IN INTERVENTIONAL X-RAY MARKET, COMPANY LANDSCAPE

  • 11.1 COMPANY SHARE ANALYSIS: GLOBAL
  • 11.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
  • 11.3 COMPANY SHARE ANALYSIS: EUROPE
  • 11.4 COMPANY SHARE ANALYSIS: ASIA PACIFIC

12 COMPANY PROFILES

  • 12.1 BRACCO
    • 12.1.1 COMPANY SNAPSHOT
    • 12.1.2 GEOGRAPHICAL PRESENCE
    • 12.1.3 COMPANY SHARE ANALYSIS
    • 12.1.4 PRODUCT PORTFOLIO
    • 12.1.5 RECENT DEVELOPMENTS
  • 12.2 GENERAL ELECTRIC COMPANY
    • 12.2.1 COMPANY SNAPSHOT
    • 12.2.2 REVENEUE ANALYSIS
    • 12.2.3 COMPANY SHARE ANALYSIS
    • 12.2.4 PRODUCT PORTFOLIO
    • 12.2.5 RECENT DEVELOPMENTS
  • 12.3 GUERBET
    • 12.3.1 COMPANY SNAPSHOT
    • 12.3.2 REVENEUE ANALYSIS
    • 12.3.3 COMPANY SHARE ANALYSIS
    • 12.3.4 PRODUCT PORTFOLIO
    • 12.3.5 RECENT DEVELOPMENTS
  • 12.4 FUJIFILM VISUALSONICS INC.
    • 12.4.1 COMPANY SNAPSHOT
    • 12.4.2 GEOGRAPHICAL PRESENCE
    • 12.4.3 PRODUCT PORTFOLIO
    • 12.4.4 RECENT DEVELOPMENT
  • 12.5 IMAX
    • 12.5.1 COMPANY SNAPSHOT
    • 12.5.2 GEOGRAPHICAL PRESENCE
    • 12.5.3 PRODUCT PORTFOLIO
    • 12.5.4 RECENT DEVELOPMENT
  • 12.6 J.B. CHEMICALS & PHARMACEUTICALS LTD.
    • 12.6.1 COMPANY SNAPSHOT
    • 12.6.2 REVENUE ANALYSIS
    • 12.6.3 PRODUCT PORTFOLIO
    • 12.6.4 RECENT DEVELOPMENT
  • 12.7 JODAS EXPOIM
    • 12.7.1 COMPANY SNAPSHOT
    • 12.7.2 GEOGRAPHICAL PRESENCE
    • 12.7.3 PRODUCT PORTFOLIO
    • 12.7.4 RECENT DEVELOPMENTS
  • 12.8 LANTHEUS MEDICAL IMAGING, INC.
    • 12.8.1 COMPANY SNAPSHOT
    • 12.8.2 REVENUE ANALYSIS
    • 12.8.3 PRODUCT PORTFOLIO
    • 12.8.4 RECENT DEVELOPMENTS
  • 12.9 NANO THERAPEUTICS PVT. LTD.
    • 12.9.1 COMPANY SNAPSHOT
    • 12.9.2 GEOGRAPHICAL PRESENCE
    • 12.9.3 PRODUCT PORTFOLIO
    • 12.9.4 RECENT DEVELOPMENT
  • 12.10 NOVALEK PHARMACEUTICALS PVT. LTD.
    • 12.10.1 COMPANY SNAPSHOT
    • 12.10.2 GEOGRAPHICAL PRESENCE
    • 12.10.3 PRODUCT PORTFOLIO
    • 12.10.4 RECENT DEVELOPMENT
  • 12.11 TAEJOON PHARM
    • 12.11.1 COMPANY SNAPSHOT
    • 12.11.2 GEOGRAPHICAL PRESENCE
    • 12.11.3 PRODUCT PORTFOLIO
    • 12.11.4 RECENT DEVELOPMENT
  • 12.12 UNIJULES LIFE SCIENCES LTD.
    • 12.12.1 COMPANY SNAPSHOT
    • 12.12.2 PRODUCT PORTFOLIO
    • 12.12.3 RECENT DEVELOPMENT

13 QUESTIONNAIRE

14 RELATED REPORTS

Back to Top